Formycon and its commercialization partner Fresenius Kabi have announced that the US Food and Drug Administration (FDA) has ...

Markets expect rate cuts — but your earnings don’t have to suffer. Lock in 7.2% until 2028 from ten individual bonds. Based ...

The current earnings multiple is quite low if you take out non-recurring items (NRI). The company now has two operating engines after spinning off consumer brand Kenvue in 2023. Those businesses ...

Stonebrook Private Inc. slightly reduced its position in Johnson & Johnson, selling 2,057 shares, yet still holds $3.24 ...

Uncertainty continues to grip markets as the Donald Trump administration signals a potential return to aggressive trade ...

Cramer noted that investors are skirting Johnson & Johnson (NYSE:JNJ) because of worries regarding Robert Kennedy Jr., as he ...

The U.S. FDA will convene a panel of scientific experts on May 20 to discuss the "safety and necessity" of talc as an ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Investing.com -- Bayer AG (ETR: BAYGN) is making a renewed effort to resolve the thousands of lawsuits alleging its Roundup weedkiller causes cancer, while simultaneously preparing for a possible ...

Following a third failed bankruptcy maneuver by Johnson & Johnson (NYSE: JNJ), trial lawyers with Dallas-based Nachawati Law Group have filed three new lawsuits on behalf of women who developed cancer ...

Johnson & Johnson is a dividend king stock whose strong product line and consistency has earned it a listing on the Dow Jones ...